Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Milan Piya"'
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Public health researchpractice. 32(3)
This paper aims to identify challenges in current health service approaches to providing optimal care for people who seek treatment for obesity. Type of program or service: Health service management of obesity in Australia Methods: Drawing on lived e
Autor:
Robert Cuddihy, Rebeca Reyes-Garcia, Eduardo Hernández Salazar, Pawel Bogdanski, Tanja Milicic, Mihaela Vladu, Farida Valeeva, Silvio Buscemi, Veroniek Harbers, Thomas Pieber, Jeppe Gram, Martin Haluzik, Søren Gregersen, Ismet Tamer, Prasad Gunasekaran, Jean O'Connell, Peter Lommer Kristensen, Mustafa Kemal BALCI, Robert Lindsay, Hans Prozesky, JOSE ITALO MOTA, Dilek Gogas Yavuz, Pavel Trachta, Katerina Anderlova, Lise Tarnow, Paramesh S, Miguel Camafort-Babkowski, Selcuk Dagdelen, Shu-Fu Lin, Jarmila Krizova, İSMAİL ENGİN, Marcin Kunecki, Renan Montenegro Junior, Hayriye Esra Ataoglu, IREM DINÇER, John Buse, Jose Sgarbi, Christopher Gilfillan, Tatiana Kiseleva, Henna Cederberg, Sadi Ozdem, Chung-Huei Huang, Miljanka Vuksanovic, Sten Madsbad, Milan Piya, Patrick English, Yu-Yao Huang, Monika Zurawska-Klis, Alan Jaap, Alessandro Mattina, MARIANNA MARANGHI
Publikováno v:
New England Journal of Medicine
Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. METHODS In this double-blind trial, we randomly assigned patients with type 2 diabetes and hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3beb7f3304e6b754eeb3ba9c143961e
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/417
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/417